Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
about
Inhibition of corneal neovascularization by topical and subconjunctival tigecycline.Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms.Minocycline inhibits alkali burn-induced corneal neovascularization in miceDoxycycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularizationDoxycycline prevents matrix remodeling and contraction by trichiasis-derived conjunctival fibroblasts.Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats.Oxidative stress to the cornea, changes in corneal optical properties, and advances in treatment of corneal oxidative injuries.Doxycycline Inhibits IL-17-Stimulated MMP-9 Expression by Downregulating ERK1/2 Activation: Implications in Myogenic DifferentiationComprehensive Modeling of Corneal Alkali Injury in the Rat Eye.Oral Doxycycline Reduces the Total Number of Intraocular Bevacizumab Injections Needed to Control Neovascular Age-related Macular Degeneration.The effect of topical doxycycline on corneal neovascularization.Comparison of the Effects of Subconjunctival Injections of Bevacizumab and Interferon Alpha-2a on Corneal Angiogenesis in a Rat Model
P2860
Q34114441-70F91CF2-E3C3-46F7-A46C-C6E3D94DC4EAQ34277464-054B6CA7-1CA4-458E-B233-C0C7754DDF3BQ34359185-82BB2C1C-77B6-4A5F-B86B-374B40811EF8Q35087983-995E57D1-8CEF-4143-AC44-C7BA86E3BF20Q37013567-3D7F0C2C-8C84-44AC-82C7-B337C4352DCBQ37446439-4E7CB178-CE80-4D73-AA1F-D3AF81E1975BQ38414851-5BE0233E-C478-4308-A069-92D35CEE6F2FQ38723327-6FE29170-E73E-4148-BE82-A46D6FC4A0F0Q47849678-908A41D8-87AE-420F-9DBA-CA5EB019D9EDQ48524275-F7B7FC6B-47CF-4343-8C42-853E76BF7FA1Q53097781-B084A30E-3CCD-46BF-B717-A6281E8E26C6Q57825810-DB2E4FE8-5249-442D-8FB9-A0F935827C04
P2860
Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Doxycycline enhances the inhib ...... and prevents its side effects.
@en
Doxycycline enhances the inhib ...... and prevents its side effects.
@nl
type
label
Doxycycline enhances the inhib ...... and prevents its side effects.
@en
Doxycycline enhances the inhib ...... and prevents its side effects.
@nl
prefLabel
Doxycycline enhances the inhib ...... and prevents its side effects.
@en
Doxycycline enhances the inhib ...... and prevents its side effects.
@nl
P2093
P356
P1476
Doxycycline enhances the inhib ...... and prevents its side effects.
@en
P2093
Chuanbin Wu
Miaoli Lin
Yongping Li
Zhanrong Li
P304
P356
10.1167/IOVS.11-7255
P407
P50
P577
2011-11-25T00:00:00Z